Abstract: A therapeutic composition of lorazepam and its pharmaceutically acceptable derivatives are provided for intranasal administration of at least one predetermined volumetric unit dose in the form of a spray by means that delivers one or more therapeutically prescribed unit doses that are highly accurate as to the volume discharged and which leave no significant quantity of the composition in the delivery means.
Type:
Grant
Filed:
February 20, 2001
Date of Patent:
August 26, 2003
Assignee:
University of Kentucky Research Foundation